Xeris Pharmaceuticals Inc (XERS) financials · rev $291.8M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Xeris Pharmaceuticals Inc (XERS) rev $291.8M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $291.8M | $203.1M |
| Operating Income | $24.9M | -$33.6M |
| Net Income | $554.0K | -$54.8M |
| EPS (Diluted) | N/A | -$0.37 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $383.5M | $323.1M |
| Current Assets | $240.3M | $167.7M |
| Cash & Equivalents | $111.0M | $71.6M |
| Inventory | $68.7M | $48.2M |
| PP&E | $4.95M | $5.56M |
| Total Liabilities | $369.8M | $352.7M |
| Current Liabilities | $109.6M | $100.4M |
| Short-term Debt | N/A | $15.1M |
| Long-term Debt | $220.3M | $217.0M |
| Total Debt | $220.3M† | $232.1M† |
| Shareholders' Equity | $13.7M | -$29.6M |
| Retained Earnings | -$671.3M | -$671.9M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $28.6M | -$37.0M |
| Investing Cash Flow | -$696.0K | $4.88M |
| Financing Cash Flow | $11.4M | $36.2M |
| Net Change in Cash | $39.3M | $4.07M |
FAQ
What is XERS P/E and revenue?
Xeris Pharmaceuticals Inc (XERS) rev $291.8M.
What is XERS revenue?
Xeris Pharmaceuticals Inc last cached revenue is $291.8M (FY2025).
Is XERS profitable?
Xeris Pharmaceuticals Inc last cached net income is $554.0K (FY2025).
What are XERS total assets?
Xeris Pharmaceuticals Inc last cached total assets are $383.5M (FY2025).
What is XERS free cash flow?
No cached cash-flow row for XERS yet.
Not investment advice. Cached statements, not a live tape.